Overview

Nigelle 5CH in Prevention of Influanza

Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
This study will be carried out by more than 30 liberal Tunisian doctors, who will submit according to the inclusion / exclusion criteria of people who will receive (free of charge) a capsule of the Nig5 product sublingually, each day. Against a control group which will be followed with the same protocol as the first but which will not receive the product. Randomization (even days: nigella group, odd days: control group)
Phase:
N/A
Details
Lead Sponsor:
Hôpital Universitaire Sahloul